Schonfeld Strategic Advisors LLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1665241 NEW YORK, NY

Position in PTCT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$21,692,932

+$20,270,805 QoQ

Shares Held

318,405

+1274.0% QoQ

Ownership

3.84%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $295,816,121 across 125 Biotechnology names. PTCT ranks #3 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc. This page	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,692,932	318,405	+1274.0%	Shares	Sole	2026-05-15
2025-09-30	$1,422,127	23,173	-45.2%	Shares	Sole	2025-11-14
2025-06-30	$2,063,929	42,259	-35.8%	Shares	Sole	2025-08-14
2025-03-31	$3,355,766	65,851	-46.1%	Shares	Sole	2025-05-15
2024-12-31	$5,519,719	122,280	-35.4%	Shares	Sole	2025-02-14
2024-09-30	$7,020,544	189,233	+584.1%	Shares	Sole	2024-11-14
2024-06-30	$845,873	27,661	+381.5%	Shares	Sole	2024-08-14
2022-09-30	$288,399	5,745	-84.8%	Shares	Sole	2022-11-14
2022-06-30	$1,513,066	37,770	-37.2%	Shares	Sole	2022-08-15
2021-06-30	$2,540,427	60,100	+626.0%	Shares	Sole	2021-11-16
2020-03-31	$369,281	8,278	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.